{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:21:29Z","timestamp":1782537689408,"version":"3.54.5"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007802","name":"Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.neures.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T16:36:56Z","timestamp":1694104616000},"page":"31-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0667-2396","authenticated-orcid":false,"given":"Luisa","family":"Donini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Tanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Zuccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9278-8960","authenticated-orcid":false,"given":"Manuela","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2023.09.002_bib1","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00415-020-09761-z","article-title":"Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis","volume":"267","author":"Abu-Rumeileh","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2021-000143","article-title":"Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis","volume":"3","author":"Alagaratnam","year":"2021","journal-title":"BMJ Neurol. Open"},{"key":"10.1016\/j.neures.2023.09.002_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","article-title":"The epidemiology of ALS: a conspiracy of genes, environment and time","volume":"9","author":"Al-Chalabi","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib4","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.18632\/aging.101551","article-title":"YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression","volume":"10","author":"Andr\u00e9s-Benito","year":"2018","journal-title":"Aging"},{"key":"10.1016\/j.neures.2023.09.002_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/genes14020325","article-title":"Extracellular vesicles as potential biomarkers in amyotrophic lateral sclerosis","volume":"14","author":"Barbo","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.neures.2023.09.002_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/jnnp-2019-322476","article-title":"Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion","volume":"91","author":"Barschke","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib7","first-page":"10","article-title":"Extracellular vesicles and a novel form of communication in the brain","author":"Basso","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib8","doi-asserted-by":"crossref","first-page":"15295","DOI":"10.1038\/s41598-020-72247-5","article-title":"Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosis","volume":"10","author":"Beers","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neures.2023.09.002_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01499-6","article-title":"Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics","volume":"11","author":"Behzadi","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.neures.2023.09.002_bib10","article-title":"Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal","author":"Benatar","year":"2022","journal-title":"Brain awac394"},{"key":"10.1016\/j.neures.2023.09.002_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion","volume":"84","author":"Benatar","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/21678421.2019.1646769","article-title":"Neurofilaments in pre-symptomatic ALS and the impact of genotype","volume":"20","author":"Benatar","year":"2019","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neures.2023.09.002_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","author":"Benatar","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2023.09.002_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jocn.2015.10.008","article-title":"Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"26","author":"Benninger","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41598-020-80370-6","article-title":"Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS","volume":"11","author":"Brodovitch","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neures.2023.09.002_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"10.1016\/j.neures.2023.09.002_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.neures.2023.09.002_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s13760-017-0855-y","article-title":"Serum troponin T in patients with amyotrophic lateral sclerosis","volume":"119","author":"Casmiro","year":"2019","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.neures.2023.09.002_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab274","article-title":"Teaching an old dog new tricks: serum troponin T as a biomarker in amyotrophic lateral sclerosis","author":"Castro-Gomez","year":"2021","journal-title":"Brain Commun. 3, fcab274"},{"key":"10.1016\/j.neures.2023.09.002_bib20","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/cells9051174","article-title":"Creatine kinase and progression rate in amyotrophic lateral sclerosis","volume":"9","author":"Ceccanti","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neures.2023.09.002_bib21","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/neu.480251106","article-title":"The p75 neurotrophin receptor","volume":"25","author":"Chao","year":"1994","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neures.2023.09.002_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.celrep.2017.09.037","article-title":"p75 is required for the establishment of postnatal sensory neuron diversity by potentiating ret signaling","volume":"21","author":"Chen","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neures.2023.09.002_bib23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/cells12040597","article-title":"TDP-43 proteinopathy specific biomarker development","volume":"12","author":"Cordts","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neures.2023.09.002_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.26462","article-title":"Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis","volume":"92","author":"Cousins","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib25","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/genes14081658","article-title":"Neuroinflammatory pathways in the ALS-FTD continuum: a focus on genetic variants","volume":"14","author":"De Marchi","year":"2023","journal-title":"Genes"},{"issue":"4","key":"10.1016\/j.neures.2023.09.002_bib26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jnnp-2019-322309","article-title":"Neurofilament light chain and C reactive protein explored as predictors of survival in amyotrophic lateral sclerosis","volume":"91","author":"De Schaepdryver","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.neures.2023.09.002_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","article-title":"Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"89","author":"De Schaepdryver","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib28","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/acn3.50890","article-title":"Serum neurofilament heavy chains as early marker of motor neuron degeneration","volume":"6","author":"De Schaepdryver","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/jnnp-2020-323372","article-title":"Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis","volume":"91","author":"Dorst","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jnnp-2021-327503","article-title":"Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis","volume":"93","author":"Dreger","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib31","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.neures.2023.09.002_bib32","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/ene.15321","article-title":"Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis","volume":"29","author":"Falzone","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.neures.2023.09.002_bib33","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1007\/s00415-020-09838-9","article-title":"Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease","volume":"267","author":"Falzone","year":"2020","journal-title":"J Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib34","series-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","author":"FDA-NIH Biomarker Working Group","year":"2016"},{"key":"10.1016\/j.neures.2023.09.002_bib35","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.neures.2023.09.002_bib36","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fnins.2018.00574","article-title":"Role of extracellular vesicles in amyotrophic lateral sclerosis","volume":"12","author":"Ferrara","year":"2018","journal-title":"Front Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib37","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/hmg\/3.10.1757","article-title":"Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis","volume":"3","author":"Figlewicz","year":"1994","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neures.2023.09.002_bib38","first-page":"2018","article-title":"Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis","author":"Gille","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry jnnp-"},{"issue":"3","key":"10.1016\/j.neures.2023.09.002_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/nan.12511","article-title":"Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis","volume":"45","author":"Gille","year":"2019","journal-title":"Neuropathol Appl Neurobiol."},{"key":"10.1016\/j.neures.2023.09.002_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.991143","article-title":"CSF p-tau as a potential cognition impairment biomarker in ALS","volume":"13","author":"Gong","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/21678421.2020.1779300","article-title":"A multi-center study of neurofilament assay reliability and inter-laboratory variability","volume":"21","author":"Gray","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neures.2023.09.002_bib43","doi-asserted-by":"crossref","first-page":"45951","DOI":"10.1074\/jbc.M408139200","article-title":"A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis","volume":"279","author":"Gros-Louis","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2023.09.002_bib44","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/cells12060909","article-title":"Neurofilament levels in dendritic spines associate with synaptic status","volume":"12","author":"G\u00fcrth","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neures.2023.09.002_bib45","doi-asserted-by":"crossref","first-page":"9269","DOI":"10.1523\/JNEUROSCI.0147-18.2019","article-title":"Extracellular vesicles and neurodegenerative diseases","volume":"39","author":"Hill","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.actbio.2020.10.009","article-title":"Polymeric nanoparticles functionalized with muscle-homing peptides for targeted delivery of phosphatase and tensin homolog inhibitor to skeletal muscle","volume":"118","author":"Huang","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.neures.2023.09.002_bib47","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acn3.51078","article-title":"Longitudinal biomarkers in amyotrophic lateral sclerosis","volume":"7","author":"Huang","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib48","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41598-017-05430-w","article-title":"Urinary extracellular domain of neurotrophin receptor p75 as a biomarker for amyotrophic lateral sclerosis in a Chinese cohort","volume":"7","author":"Jia","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neures.2023.09.002_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.03.048","article-title":"MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis","volume":"708","author":"Katsu","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neures.2023.09.002_bib50","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib51","doi-asserted-by":"crossref","first-page":"11682","DOI":"10.3390\/ijms241411682","article-title":"Creatine kinase MB isoenzyme is a complementary biomarker in amyotrophic lateral sclerosis","volume":"24","author":"Kittipeerapat","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.neures.2023.09.002_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/21678421.2021.1939384","article-title":"Cardiac troponin T is elevated and increases longitudinally in ALS patients","volume":"23","author":"Kl\u00e4ppe","year":"2022","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neures.2023.09.002_bib53","series-title":"Targeting Chitin-Containing Organisms, Advances in Experimental Medicine and Biology","first-page":"221","article-title":"Human chitinases: structure, function, and inhibitor discovery","author":"Kumar","year":"2019"},{"key":"10.1016\/j.neures.2023.09.002_bib54","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","article-title":"TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration","volume":"19","author":"Lagier-Tourenne","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neures.2023.09.002_bib55","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/acn3.51141","article-title":"UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis","volume":"7","author":"Li","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.739016","article-title":"Extracellular vesicles in serum and central nervous system tissues contain microRNA signatures in sporadic amyotrophic lateral sclerosis","volume":"14","author":"Lo","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib57","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1007\/s00415-020-10047-7","article-title":"Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis","volume":"267","author":"Lunetta","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13760-015-0596-8","article-title":"Elevation of cardiac troponin T in patients with amyotrophic lateral sclerosis","volume":"116","author":"Mach","year":"2016","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.neures.2023.09.002_bib59","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2021-327877","article-title":"Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis","volume":"93","author":"Masrori","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib61","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neures.2023.09.002_bib62","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1253\/circj.CJ-13-0706","article-title":"Cardiac troponin T: \u2013 from diagnosis of myocardial infarction to cardiovascular risk prediction","volume":"77","author":"Mueller","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.neures.2023.09.002_bib63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neures.2023.09.002_bib64","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1021\/acs.jproteome.7b00660","article-title":"Comparison of internal standard approaches for SRM analysis of alpha-synuclein in cerebrospinal fluid","volume":"17","author":"Oeckl","year":"2018","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.neures.2023.09.002_bib65","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jnnp-2018-318868","article-title":"Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase","volume":"90","author":"Oeckl","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5-6","key":"10.1016\/j.neures.2023.09.002_bib66","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/21678421.2016.1167913","article-title":"Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS","volume":"17","author":"Oeckl","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neures.2023.09.002_bib67","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000697","article-title":"Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis","volume":"7","author":"Olesen","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.neures.2023.09.002_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12920-019-0473-z","article-title":"Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid","volume":"12","author":"Otake","year":"2019","journal-title":"BMC Med Genom."},{"key":"10.1016\/j.neures.2023.09.002_bib69","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1093\/brain\/awab333","article-title":"Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"144","author":"Pasetto","year":"2021","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib70","first-page":"32","article-title":"Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post\u2010mortem motor cortex and cerebrospinal fluid","author":"Petrozziello","year":"2022","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neures.2023.09.002_bib71","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3389\/fneur.2018.01167","article-title":"Diagnostic and prognostic performance of neurofilaments in ALS","volume":"9","author":"Poesen","year":"2019","journal-title":"Front. Neurol."},{"issue":"24","key":"10.1016\/j.neures.2023.09.002_bib72","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2023.09.002_bib73","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2023.09.002_bib74","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1080\/15548627.2022.2124500","article-title":"Autophagy is a novel pathway for neurofilament protein degradation in vivo","volume":"19","author":"Rao","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.neures.2023.09.002_bib75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","article-title":"ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration","volume":"73","author":"Ravits","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2023.09.002_bib76","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/jnc.15451","article-title":"Is there a role for the p75 neurotrophin receptor in mediating degeneration during oxidative stress and after hypoxia?","volume":"158","author":"Sankorrakul","year":"2021","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neures.2023.09.002_bib77","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainres.2018.12.016","article-title":"Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients","volume":"1708","author":"Saucier","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neures.2023.09.002_bib78","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00415-018-9008-3","article-title":"Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis","volume":"265","author":"Scarafino","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib79","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jacc.2018.01.070","article-title":"Elevated cardiac troponin T in patients with skeletal myopathies","volume":"71","author":"Schmid","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.neures.2023.09.002_bib80","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","article-title":"A proposal for new diagnostic criteria for ALS","volume":"131","author":"Shefner","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neures.2023.09.002_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087398","article-title":"The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis","volume":"9","author":"Shepheard","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neures.2023.09.002_bib82","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1212\/WNL.0000000000003741","article-title":"Urinary p75 ECD: a prognostic, disease progression, and pharmacodynamic biomarker in ALS","volume":"88","author":"Shepheard","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2023.09.002_bib83","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/ene.15237","article-title":"Urinary neopterin: a novel biomarker of disease progression in amyotrophic lateral sclerosis","volume":"29","author":"Shepheard","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib84","first-page":"4","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5\u201390 years","author":"Simr\u00e9n","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.neures.2023.09.002_bib85","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fnins.2019.00344","article-title":"Leukocyte derived microvesicles as disease progression biomarkers in slow progressing amyotrophic lateral sclerosis patients","volume":"13","author":"Sproviero","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib86","first-page":"14","article-title":"Extracellular vesicles derived from plasma of patients with neurodegenerative disease have common transcriptomic profiling","author":"Sproviero","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-022-00515-1","article-title":"Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis","volume":"17","author":"Staats","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neures.2023.09.002_bib88","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jnnp-2017-317138","article-title":"Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression","volume":"89","author":"Steinacker","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib89","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/21678421.2020.1861023","article-title":"Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study","volume":"22","author":"Steinacker","year":"2021","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neures.2023.09.002_bib90","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2009.05.008","article-title":"Neopterin, a prognostic marker in human malignancies","volume":"287","author":"Sucher","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neures.2023.09.002_bib91","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.clinph.2018.01.071","article-title":"Creatine kinase level and its relationship with quantitative electromyographic characteristics in amyotrophic lateral sclerosis","volume":"129","author":"Tai","year":"2018","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neures.2023.09.002_bib92","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.neures.2023.09.002_bib93","first-page":"2019","article-title":"Untangling neuroinflammation in amyotrophic lateral sclerosis","author":"Thompson","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry jnnp"},{"key":"10.1016\/j.neures.2023.09.002_bib94","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.25143","article-title":"Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis: CSF macrophage biomarkers in ALS","volume":"83","author":"Thompson","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib95","first-page":"17","article-title":"CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis","author":"Thompson","year":"2020","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.neures.2023.09.002_bib96","first-page":"4","article-title":"Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain","author":"Thompson","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.neures.2023.09.002_bib97","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/ene.14063","article-title":"Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis","volume":"27","author":"Thouvenot","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib98","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jnnp-2022-330709","article-title":"Elevated plasma p-tau181 levels unrelated to Alzheimer\u2019s disease pathology in amyotrophic lateral sclerosis","volume":"94","author":"Vacchiano","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.753242","article-title":"Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study","volume":"13","author":"Vacchiano","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nurt.2010.05.012","article-title":"Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes","volume":"7","author":"Vargas","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neures.2023.09.002_bib101","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12974-020-01909-y","article-title":"Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation","volume":"17","author":"Varghese","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neures.2023.09.002_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.679199","article-title":"Neurofilament light chain as biomarker for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"15","author":"Verde","year":"2021","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.neures.2023.09.002_bib103","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib104","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/acn3.51708","article-title":"Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis","volume":"10","author":"Verde","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neures.2023.09.002_bib105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jnnp-2019-321916","article-title":"Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes","volume":"91","author":"Vu","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib106","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2018-319377","article-title":"Differences in inflammatory profiles between ALS and FTD","volume":"90","author":"Vucic","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neures.2023.09.002_bib107","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/mus.27392","article-title":"Gold Coast diagnostic criteria: implications for ALS diagnosis and clinical trial enrollment","volume":"64","author":"Vucic","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neures.2023.09.002_bib108","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib109","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1515\/cclm-2019-0015","article-title":"Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches","volume":"57","author":"Wilke","year":"2019","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.neures.2023.09.002_bib110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12031-019-01411-y","article-title":"Targeted multiple reaction monitoring analysis of CSF identifies UCHL1 and GPNMB as candidate biomarkers for ALS","volume":"69","author":"Zhu","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neures.2023.09.002_bib111","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-020-00406-3","article-title":"Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers","volume":"15","author":"Zucchi","year":"2020","journal-title":"Mol. Neurodegener."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010223001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010223001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T10:35:30Z","timestamp":1759142130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010223001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":111,"alternative-id":["S0168010223001670"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2023.09.002","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2023.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}